What is the prevalence of Trimethylaminuria?

Trimethylaminuria is a rare metabolic condition with an unknown exact prevalence, though it is widely considered significantly underdiagnosed. While precise global statistics are unavailable, Trimethylaminuria is classified as a rare disorder, with experts noting that many individuals likely live with mild or intermittent symptoms without ever receiving a formal clinical diagnosis.

Is the prevalence of Trimethylaminuria accurately known?

The true prevalence of Trimethylaminuria remains difficult to determine due to a high rate of underdiagnosis and misdiagnosis. Because the primary symptom—a characteristic body odor—is often managed through lifestyle changes or hygiene, many people never seek medical testing. According to the NIH Genetic and Rare Diseases Information Center (GARD), there are no reliable population-based studies to establish the exact incidence or prevalence of Trimethylaminuria globally.

Does Trimethylaminuria affect genders and ages differently?

Clinical observations suggest that Trimethylaminuria may present more frequently or severely in females. Hormonal fluctuations, specifically the influence of estrogen and progesterone, can exacerbate the metabolic deficiency associated with Trimethylaminuria. Regarding age of onset, the condition is typically genetic and present from birth, though symptoms often become more apparent or distressing during puberty or adulthood when hormonal changes occur.

Are there factors that influence the diagnosis of this condition?

Several variables complicate the tracking of Trimethylaminuria cases, including:

• Geographic and Ethnic Variation: While cases have been reported worldwide, some studies suggest a higher prevalence of specific genetic variants in certain populations.


• Symptom Severity: Many individuals experience only mild, intermittent odor, leading to low clinical reporting.


• Diagnostic Access: Specialized urine tests to measure trimethylamine levels are not universally available in all healthcare systems.

At DiseaseMaps.org, our community of 34 members living with Trimethylaminuria provides essential real-world insights, highlighting that the lived experience of the condition often involves years of searching for answers before receiving a formal diagnosis.

Next steps

• Consult a metabolic specialist or a clinical geneticist to discuss diagnostic testing.


• Keep a detailed diary of diet and symptom triggers to share with your physician.


• Join the Trimethylaminuria community at DiseaseMaps.org to connect with others who understand the diagnostic journey.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Trimethylaminuria.


• Orphanet: Trimethylaminuria (ORPHA: 3374).


• OMIM (Online Mendelian Inheritance in Man): Trimethylaminuria (Entry #602079).


• PubMed/NCBI: Reviews on FMO3 enzyme deficiency and metabolic disorders.